JP2001199891A - 家禽における骨粗鬆症の予防および処置用の医薬製品の製造のためのチルドロン酸およびその誘導体の使用 - Google Patents

家禽における骨粗鬆症の予防および処置用の医薬製品の製造のためのチルドロン酸およびその誘導体の使用

Info

Publication number
JP2001199891A
JP2001199891A JP2001005160A JP2001005160A JP2001199891A JP 2001199891 A JP2001199891 A JP 2001199891A JP 2001005160 A JP2001005160 A JP 2001005160A JP 2001005160 A JP2001005160 A JP 2001005160A JP 2001199891 A JP2001199891 A JP 2001199891A
Authority
JP
Japan
Prior art keywords
bone
osteoporosis
acid
treatment
spawning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001005160A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001199891A5 (enExample
Inventor
Thierry Bardon
ティエリー・バルドン
Dominique Thibaud
ドミニク・チボー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of JP2001199891A publication Critical patent/JP2001199891A/ja
Publication of JP2001199891A5 publication Critical patent/JP2001199891A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2001005160A 2000-01-12 2001-01-12 家禽における骨粗鬆症の予防および処置用の医薬製品の製造のためのチルドロン酸およびその誘導体の使用 Pending JP2001199891A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000356A FR2803521B1 (fr) 2000-01-12 2000-01-12 Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose
FR0000356 2000-01-12

Publications (2)

Publication Number Publication Date
JP2001199891A true JP2001199891A (ja) 2001-07-24
JP2001199891A5 JP2001199891A5 (enExample) 2008-02-28

Family

ID=8845841

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001005160A Pending JP2001199891A (ja) 2000-01-12 2001-01-12 家禽における骨粗鬆症の予防および処置用の医薬製品の製造のためのチルドロン酸およびその誘導体の使用

Country Status (15)

Country Link
US (1) US6482809B1 (enExample)
EP (1) EP1129714B1 (enExample)
JP (1) JP2001199891A (enExample)
AT (1) ATE306273T1 (enExample)
AU (1) AU783667B2 (enExample)
CZ (1) CZ2001135A3 (enExample)
DE (1) DE60113895T2 (enExample)
DK (1) DK1129714T3 (enExample)
ES (1) ES2249396T3 (enExample)
FR (1) FR2803521B1 (enExample)
HU (1) HUP0100122A3 (enExample)
IL (1) IL140839A0 (enExample)
NZ (1) NZ509285A (enExample)
SK (1) SK286583B6 (enExample)
ZA (1) ZA200100289B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301143B6 (cs) * 2005-03-10 2009-11-18 Koropecký@Igor Zpusob získávání koncentrovaného glycerolu a smesi vyšších mastných kyselin z glycerinové fáze, vznikající pri výrobe bionafty

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11315030A (ja) * 1998-02-23 1999-11-16 Pfizer Prod Inc 骨の障害の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
WO2000064516A1 (en) * 1999-04-22 2000-11-02 Hydromed Sciences A Division Of Gp Strategies Corporation Controlled delivery of bisphosphonates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11315030A (ja) * 1998-02-23 1999-11-16 Pfizer Prod Inc 骨の障害の治療

Also Published As

Publication number Publication date
SK286583B6 (sk) 2009-01-07
DE60113895D1 (de) 2006-02-23
DK1129714T3 (da) 2006-02-06
FR2803521A1 (fr) 2001-07-13
US6482809B1 (en) 2002-11-19
DE60113895T2 (de) 2006-06-22
CZ2001135A3 (cs) 2001-08-15
HUP0100122A2 (hu) 2002-03-28
IL140839A0 (en) 2002-02-10
AU783667B2 (en) 2005-11-24
HU0100122D0 (en) 2001-03-28
ES2249396T3 (es) 2006-04-01
ZA200100289B (en) 2001-07-24
EP1129714B1 (fr) 2005-10-12
ATE306273T1 (de) 2005-10-15
HUP0100122A3 (en) 2003-02-28
EP1129714A1 (fr) 2001-09-05
SK552001A3 (en) 2001-08-06
FR2803521B1 (fr) 2002-10-25
NZ509285A (en) 2002-05-31
AU1114101A (en) 2001-07-19

Similar Documents

Publication Publication Date Title
UA116587C2 (uk) Композиція, застосовна для активації жіночої репродуктивної здатності
US6521266B1 (en) Composition for growth hormone production and release, appetite suppression, and methods related thereto
US10792324B2 (en) Compositions and methods for the treatment of orthopedic ailments
JP2001199891A (ja) 家禽における骨粗鬆症の予防および処置用の医薬製品の製造のためのチルドロン酸およびその誘導体の使用
KR102376603B1 (ko) 제니스테인 포스페이트 콘쥬게이트의 조성물의, 골량의 감소와 관련된 질환의 치료 또는 예방을 위한 사용 및 골 구조 및 골의 생체역학 강도를 개선하기 위한 사용
JP3604710B2 (ja) 骨粗鬆症予防及び治療剤
US6649601B2 (en) Process for increasing the egg production and strengthening the eggshells of poultry
EP3277266A1 (en) Oral solid dosage form of amlodipine and veterinary uses thereof
JP2004010533A (ja) 軟骨生成促進剤及び軟骨損傷由来疾病予防治療剤
JP2005060303A (ja) 不動性骨粗鬆の治療または予防剤
JP2001199891A5 (enExample)
KR20220032874A (ko) 2,4,6-트리페닐-1-헥센을 유효성분으로 포함하는 골질환 예방 또는 치료용 조성물
TWI474826B (zh) 治療及／或預防骨質疏鬆症之組合物
Schober et al. PTH as a treatment for long bone fracture nonunion
Harutyunyan Development of bone formation on pig model of maxillary sinus augmentation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110426

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111011